Investments and Other Marketable Securities (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
|---|
| Marketable Securities [Abstract] |
|
| Schedule of Investments |
Investments on the accompanying Consolidated Balance Sheets consist of: | | | | | | | | | | | | | | | | | March 31, 2026 | | December 31, 2025 | | Available for sale debt securities | | $ | 161,221 | | | $ | 158,690 | | | Investment products and equities | | 67,379 | | | 67,414 | | | Investments in affiliated funds | | 12,389 | | | 11,593 | | | Investments in limited partnership funds | | 1,281 | | | 1,158 | | | Equity method investments (See Note 2) | | 89,101 | | | 189,149 | | | Total | | $ | 331,371 | | | $ | 428,004 | |
|
| Schedule of Available-for-Sale and Equity Securities |
The Company's available-for-sale debt securities consist of | | | | | | | | | | | | | | | | | | | | | | | | | | At March 31, 2026 | | | Cost
Amount | | Gross
Unrealized
Gains | | Gross
Unrealized
(Losses) | | Fair
Value | Mortgage-backed securities issued by GNMA | $ | 154,494 | | | $ | — | | | $ | (5,866) | | | $ | 148,628 | | | Corporate and government agency debt securities | 12,585 | | | 8 | | | — | | | 12,593 | | | $ | 167,079 | | | $ | 8 | | | $ | (5,866) | | | $ | 161,221 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | At December 31, 2025 | | | Cost
Amount | | Gross
Unrealized
Gains | | Gross
Unrealized
(Losses) | | Fair
Value | Mortgage-backed securities issued by GNMA | $ | 163,071 | | | $ | — | | | $ | (4,381) | | | $ | 158,690 | | | | | | | | | | | $ | 163,071 | | | $ | — | | | $ | (4,381) | | | $ | 158,690 | |
Unrealized holding losses, net of income tax benefit, at March 31, 2026 and December 31, 2025 of available-for-sale debt securities were: | | | | | | | | | | | | | | | | | March 31, 2026 | | December 31, 2025 | | Unrealized holding losses | | $ | (5,866) | | | $ | (4,381) | | | Less: Income tax benefit | | 1,349 | | | 1,008 | | | Unrealized holding losses, net of tax | | (4,517) | | | (3,373) | |
|
| Schedule of Available-for-Sale Debt Securities by Maturity |
The following tables provide the scheduled maturities of the Company's available-for-sale debt securities: | | | | | | | | | | | | | | | | | At March 31, 2026 | | | Cost | | Fair Value | | Within one year | | $ | 12,585 | | | $ | 12,593 | | | After one year through five years | | 2,806 | | | 2,503 | | | After 5 years through 10 years | | 21,618 | | | 19,818 | | | After 10 years | | 130,070 | | | 126,307 | | | | | $ | 167,079 | | | $ | 161,221 | |
| | | | | | | | | | | | | | | | | At December 31, 2025 | | | Cost | | Fair Value | | Within one year | | $ | — | | | $ | — | | | After one year through five years | | 3,248 | | | 2,930 | | | After 5 years through 10 years | | 14,789 | | | 13,787 | | | After 10 years | | 145,034 | | | 141,973 | | | | | $ | 163,071 | | | $ | 158,690 | |
|